Ligand Pharmaceuticals | LGND - UTANG





UTANG Perubahan Tanggal
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 57.32B 2.72B 2026-03
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 983.69M 5.77M 2026-06
Baxter International USD 9.69B 93M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Enviri Corporation USD 1.44B 3.08M 2024-12
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 725.8M 1.82M 2026-06
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
MacroGenics USD 36.51M 500K 2026-03
Merck USD 49.12B 222M 2026-03
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 39.33M 321K 2026-03